A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.
Therese Swan, BA
Advertisement
Articles by Therese Swan, BA
Advertisement
Latest Updated Articles
- Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients
Published: September 7th 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
3
Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets
4
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
5